Peak Bio - Crunchbase Company Profile & Funding

Q: Where is Peak Bio's headquarters?

Peak Bio is located in Palo Alto, California, United States.

Q: Who invested in Peak Bio?

Peak Bio has 2 investors including Hoyoung Huh And Palo Alto Investors.

Q: When was the last funding round for Peak Bio?

Peak Bio closed its last funding round on obfuscated from a Post-IPO Equity round.

Q: How much funding has Peak Bio raised to date?

Peak Bio has raised obfuscated.

Overview

Peak Bio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Peak Bio

CB Rank

80302

Peak Bio is a biopharmaceutical company that focuses on the drug development to treat Oncology and Inflammatory diseases.

Acquired by

Akari Therapeutics

Founded

obfuscation

Delisted

Post-IPO Equity

Palo Alto, California, United States

11-50

peak-bio.com/

Biopharma

Biotechnology

Oncology

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Details

Sub-Organization of

Akari Therapeutics

Legal Name

Peak Bio Inc.

Operating Status

Active

Stock Symbol

OTCQB:PKBO

Company Type

For Profit

Founders

Hoyoung Huh

About the Company

Peak Bio is a Biopharmaceutical company that focuses on the drug development to treat Oncology and Inflammatory diseases.

Phone Number

+1-650-549-9103

Contact Email

Admin@peak-bio.com

Predictions & Insights

Products & Services

Trop2 Antibody Drug Conjugate (ADC)

An ADC targeting Trop2 antigen on solid tumors using a spliceosome modulator payload to induce cancer cell death and immune response.

PHP-303 Neutrophil Elastase Inhibitor

An oral small molecule inhibitor of neutrophil elastase for treating alpha-1 antitrypsin deficiency and exploring acute respiratory distress syndrome.

Research & Development

Peak Bio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Peak Bio	2	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Peak Bio	2	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Peak Bio	2	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Peak Bio	2	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Peak Bio	2	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Peak Bio	2	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Peak Bio	2	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Peak Bio	2	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Peak Bio	2	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Peak Bio	2	obfuscated obfuscation	—	Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Hoyoung Huh	—	Post-IPO Equity - Peak Bio	—
Hoyoung Huh	—	Post-IPO Equity - Peak Bio	—
Hoyoung Huh	—	Post-IPO Equity - Peak Bio	—
Hoyoung Huh	—	Post-IPO Equity - Peak Bio	—
Hoyoung Huh	—	Post-IPO Equity - Peak Bio	—